Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 156   

Articles published

MRK 57.50 -0.27 (-0.47%)
price chart
Merck & Co Inc (NYSE:MRK) � Merck and Award-Winning Actress S. Epatha ...
Merck & Co Inc (NYSE:MRK) [PR Newswire] - WHITEHOUSE STATION, N.J., April 23, 2014 /PRNewswire/ - Merck (MRK), known as MSD outside the United States and Canada, today announced it is teaming up with Emmy and Golden Globe-winning ...
Related articles »  
Can Merck & Co. Inc. and Bristol-Myers Squibb Co. Dethrone Gilead Sciences ...
While leader Gilead Sciences (NASDAQ: GILD ) waits on the FDA review for its combination of Sovaldi and levipasvir, and battles questions over Sovaldi's price tag, Merck is producing data on easy-to-treat populations and Bristol-Myers Squibb has turned ...
Related articles »  
Merck & Co., Inc. (NYSE:MRK): Gets The FDA Approval for RAGWITEK�
Dallas, Texas 04/23/2014 (ustradevoice) - Merck & Co., Inc. (NYSE:MRK) have received the FDA Approval for RAGWITEK�.
Merck & Co., Inc. (NYSE:MRK)'s Oncology Break-Through MK-3475 Said To ...
It is the case with the breakthrough drug from Merck & Co., Inc. (NYSE:MRK) called the MK-3475 that provides efficient results in the treatment of non-small cell lung cancer (NSCLC).
Related articles »  
Brand Face-Off: GlaxoSmithKline plc (ADR) vs. Merck & Co., Inc.
Pharmaceutical giants GlaxoSmithKline plc (ADR) (NYSE:GSK) and Merck & Co., Inc. (NYSE:MRK) have charted different paths during the last year.
Insider Selling: Merck & Co. Insider Unloads 145225 Shares of Stock (MRK)  Ticker Report
Related articles »  
Why Healthcare Stocks Surged: Merck & Co. (NYSE:MRK), Johnson & Johnson ...
Merck & Co., Inc. (NYSE:MRK) presented additional data from an ongoing phase II study on its once-daily, all-oral hepatitis C virus (:HCV) combination regimen - MK-5172 (100 mg, a NS3/4A protease inhibitor) and MK-8742 (50 mg, a NS5A replication ...
Related articles »  
Stocks to Watch Friday: Merck & Co., Inc., Deere & Company, and Toyota Motor ...
Momentum names that made notable moves on Thursday and could continue to do so into Friday's session include pharmaceutical firm Merck & Co., Inc. (NYSE:MRK), machinery concern Deere & Company (NYSE:DE), and automaker Toyota Motor Corp ...
Merck & Co. Price Target Increased to $70.00 by Analysts at MKM Partners ...  Ticker Report
Drug Most active stocks: Pfizer Inc. (NYSE:PFE), Merck & Co (NYSE:MRK ...  Gaining Green
Related articles »  
Dividend Stocks To Buy Right Now [Merck & Co., Inc., Duke Energy Corp ...
Companies increased dividend payouts by a robust $17.8 billion in Q1 2014, compared to a $14.5 billion increase in Q1 of 2013, a 14.2% year-over-year increase, according to S&P Indices.
Related articles »  
One Put, One Call Option To Know About For Merck & Co.
Consistently, one of the more popular stocks people enter into their stock options watchlist at Stock Options Channel is Merck & Co., Inc (MRK). So this week we highlight one interesting put contract, and one interesting call contract, from the May ...
Related articles »  
Merck & Co., Inc. (NYSE:MRK) Presents Immunotherapy Findings; Collaborates ...
Boston, MA 04/07/2014 (wallstreetpr) - Yesterday, Merck & Co., Inc. (NYSE:MRK) provided early discoveries associated with the relation between PD-L1 Expression and the clinical outcome of its under study Anti-PD-1 Immunotherapy, MK-3475 at AACR ...
Related articles »